Ушбу ишга иқтибос қилган ишлар

5 та иш

Иш: Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

1. Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

   Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10

   Шарҳ мақолаT-cell and B-cell ImmunologyImmunological Investigations20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000109

2. The role of hypoxia-inducible factor-1α on colon cancer progression and metastasis

   Mohamed J. Saadh, Mareb Hamed Ahmed, Rafid Jihad Albadr +9

   Шарҳ мақолаCancer, Hypoxia, and MetabolismInternational Journal of Clinical Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000121

3. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768

4. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

   Qamar Abuhassan, Ali M Atoom, M.M. Rekha +5

   МақолаPsoriasis: Treatment and PathogenesisHuman Immunology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.004934

5. Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

   Qamar Abuhassan, Hamzeh J. Al‐Ameer, Hani Moslem Ahmed +4

   МақолаCancer, Hypoxia, and MetabolismIUBMB Life20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013100